Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  AB Science    AB   FR0010557264

AB SCIENCE

(AB)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

AB Science SA : half-yearly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
08/28/2018 | 09:15am EDT

The company will report its earnings for S1 2018 on 08/31/2018. Generally, the company reports earnings in line with the consensus. In recent months, the analysts from Thomson Reuters consensus have revised their EPS estimates downward.

Stocks mentioned in the article
ChangeLast1st jan.
AB SCIENCE -1.77% 7.75 Real-time Quote.46.65%
THOMSON REUTERS CORPORATION 1.81% 94.57 Delayed Quote.3.22%

© MarketScreener.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on AB SCIENCE
03/31AB Science announces that FDA clears masitinib IND in Amyotrophic Lateral Scl..
GL
03/12SCIENCE : AB Science will present results from its Phase 3 AB07015 study in seve..
GL
03/09SCIENCE : Summary of webcast with Key Opinion Leaders on masitinib Phase 2B/3 re..
PU
03/09AB Science is providing a summary of the live webcast held on 06 March 2020 w..
GL
03/09SCIENCE : AB Science is providing a summary of the live webcast held on 06 March..
GL
03/05AB Science will host a live webcast on masitinib in Progressive Forms of Mult..
GL
03/02SCIENCE : AB Science announces a new fundraising of EUR 12.3 million
GL
03/02SCIENCE : AB Science will host a live webcast on masitinib in Progressive Forms ..
GL
03/02AB Science will host a live webcast on masitinib in Progressive Forms of Mul..
GL
02/26AB SCIENCE : Provisional calendar
CO
More news
Financials (EUR)
Sales 2019 1,55 M
EBIT 2019 -21,4 M
Net income 2019 -
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 -
Capi. / Sales2019 224x
Capi. / Sales2020 216x
Capitalization 345 M
Chart AB SCIENCE
Duration : Period :
AB Science Technical Analysis Chart | AB | FR0010557264 | MarketScreener
Technical analysis trends AB SCIENCE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 9,50  €
Last Close Price 7,75  €
Spread / Highest target 29,0%
Spread / Average Target 22,6%
Spread / Lowest Target 16,1%
Managers
NameTitle
Alain Moussy Chairman, CEO & Scientific Director
Laurent Guy Chief Financial Officer
Christian Fassotte Global Chief Medical Officer
Antonello Cervone Director-Information Technology
Edita Dolimier Head-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
AB SCIENCE46.65%340
MERCK KGAA-14.70%44 730
KYOWA KIRIN CO., LTD.-1.98%12 086
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-0.64%10 466
JAZZ PHARMACEUTICALS PLC-35.91%5 599
BETTA PHARMACEUTICALS CO., LTD.0.76%3 975